Sangamo Therapeutics
SGMO
SGMO
193 hedge funds and large institutions have $679M invested in Sangamo Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
-4
Holders Change %
-2.03%
% of All Funds
3.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
59
Reduced
65
Closed
23
Calls
$10M
Puts
$7.84M
Net Calls
+$2.2M
Net Calls Change
-$3.66M
Top Buyers
Top Sellers
| 1 |
1
JPMorgan Chase & Co
New York
|
$18.2M |
| 2 |
CC
2
Casdin Capital
New York
|
$0 |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$840K |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$20.9M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$3.55M |
